These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15453328)

  • 1. [Prediction of fulminant hepatitis in severe acute hepatitis B].
    Michitaka K; Onji M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():269-73. PubMed ID: 15453328
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical view of acute hepatitis B].
    Tanaka N; Arakawa Y; Moriyama M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():242-7. PubMed ID: 15453323
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis.
    Ehata T; Omata M; Chuang WL; Yokosuka O; Ito Y; Hosoda K; Ohto M
    J Clin Invest; 1993 Mar; 91(3):1206-13. PubMed ID: 8450049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological characteristics and clinical significance of New Inuyama Classification in chronic hepatitis B].
    Yamada G
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():290-2. PubMed ID: 15453332
    [No Abstract]   [Full Text] [Related]  

  • 8. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
    Liaw YF
    Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation.
    Takahashi Y; Kumada H; Shimizu M; Tanikawa K; Kumashiro R; Omata M; Ehata T; Tsuji T; Ukida M; Yasunaga M
    Hepatology; 1994 May; 19(5):1065-71. PubMed ID: 8175127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis B virus genotypes and mutations in asymptomatic carriers].
    Orito E; Mizokami M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():233-7. PubMed ID: 15453321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term outcome and prognostic factors for chronic hepatitis type B].
    Sakugawa H; Maeshiro T; Nakayoshi T
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():299-302. PubMed ID: 15453334
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
    Ozasa A; Tanaka Y; Orito E; Sugiyama M; Kang JH; Hige S; Kuramitsu T; Suzuki K; Tanaka E; Okada S; Tokita H; Asahina Y; Inoue K; Kakumu S; Okanoue T; Murawaki Y; Hino K; Onji M; Yatsuhashi H; Sakugawa H; Miyakawa Y; Ueda R; Mizokami M
    Hepatology; 2006 Aug; 44(2):326-34. PubMed ID: 16871568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBe antigen and HBe antibody].
    Arase Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():124-8. PubMed ID: 15453300
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dynamics of HBV-DNA level in acute hepatitis B].
    Zhao H; Cao JH; Tian GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):159-61. PubMed ID: 12870000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic tests: Serological markers of hepatitis B virus].
    Daikoku M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():404-7. PubMed ID: 16111286
    [No Abstract]   [Full Text] [Related]  

  • 18. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.
    Gérolami R; Henry M; Borentain P; Colson P; Botta D; Tamalet C
    Clin Infect Dis; 2005 Feb; 40(4):e24-7. PubMed ID: 15712066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of cirrhosis after chronic hepatitis B].
    Hazama H; Koga M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():354-7. PubMed ID: 15453345
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.